Gatifloxacin Export Market Intelligence: India's 54 Suppliers Shipping to 46 Countries — TransData Nexus 2026

Q: Who are the top gatifloxacin exporters from India?

The top gatifloxacin exporters from India are: 1. AJANTA PHARMA LIMITED — $382.5K (47.7% market share); 2. AUROLAB TRUST — $246.1K (30.7% market share); 3. DOSHI MEDICARE PRIVATE LIMITED — $27.0K (3.4% market share); 4. SUNWAYS (INDIA) PRIVATE LIMITED — $13.0K (1.6% market share); 5. SUNWAYS INDIA PRIVATE LIMITED — $6.9K (0.9% market share). Together they account for 84.2% of India's total gatifloxacin export value.

Q: What is the total export value of gatifloxacin from India?

The total export value of gatifloxacin from India is $802.0K USD, recorded across 240 shipment transactions from 54 active exporters to 46 destination countries. The average shipment value is $3.3K.

Q: Which countries import gatifloxacin from India?

India exports gatifloxacin to 46 countries worldwide. The top importing countries are: IRAQ (47.7% share, $382.5K), UGANDA (26.0% share, $208.4K), UKRAINE (9.6% share, $77.0K), SAUDI ARABIA (3.4% share, $26.9K), ESWATINI (3.1% share, $24.8K). These five markets account for 89.7% of total export value.

Q: What is the HS code for gatifloxacin exports from India?

The primary HS code for gatifloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of gatifloxacin exports from India?

The average unit price for gatifloxacin exports from India is $12.36 USD per unit, with prices ranging from $0.04 to $1466.99 depending on formulation, packaging, and order volume. The total market is valued at $802.0K across 240 shipments.

Q: Which ports handle gatifloxacin exports from India?

The primary ports for gatifloxacin exports from India are SAHAR AIR CARGO ACC (INBOM4) (20.4% of shipments), DELHI AIR CARGO ACC (INDEL4) (16.7% of shipments), SAHAR AIR (14.2% of shipments), DELHI AIR (8.3% of shipments), CHENNAI AIR CARGO ACC (INMAA4) (6.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of gatifloxacin?

India is one of the world's leading exporters of gatifloxacin due to its large base of 54 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports gatifloxacin to 46 countries, demonstrating 24% global market coverage.

Q: What certifications do Indian gatifloxacin exporters need?

Indian gatifloxacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import gatifloxacin from India?

There are 93 registered buyers importing gatifloxacin from India, spread across 46 countries. The repeat buyer rate is 48.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top gatifloxacin supplier from India?

AJANTA PHARMA LIMITED is the leading gatifloxacin exporter from India with a market share of 47.7% and total export value of $382.5K across 7 shipments. The top 5 suppliers together control 84.2% of total export value.

Suresh Sormare

Gatifloxacin

India Pharmaceutical Trade Intelligence

$802.0K54 Suppliers46 CountriesHS 30049099

ExportsIndia → IRAQ47.7%India → UGANDA26.0%

ImportsUNITED STATES → India$2.4M

#1 Supplier: AJANTA PHARMA #1 Buyer: SWASTIK PHARMACEUTICALS

Gatifloxacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Gatifloxacin to the World

Between 2022 and 2026, India exported $802.0K worth of gatifloxacin across 240 verified shipments to 46 countries — covering 24% of world markets in the Advanced Antibiotics segment. The largest destination is IRAQ (47.7%). AJANTA PHARMA LIMITED leads with a 47.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Gatifloxacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Gatifloxacin export data snapshot — $802.0K · 54 exporters · 46 countriesTransData Nexus · Indian Customs Data

Top Gatifloxacin Exporters from India

54 active exporters · Ranked by export value

View all 54 →

Top Gatifloxacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	AJANTA PHARMA LIMITED	$382.5K	7	1	47.7%
2	AUROLAB TRUST

Top Countries Importing Gatifloxacin from India

46 destination markets · Ranked by import value

All 46 countries →

Top Countries Importing Gatifloxacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	IRAQ	$382.5K	47.7%
2	UGANDA	$208.4K	26.0%
3	UKRAINE	$77.0K	9.6%
4	SAUDI ARABIA	$26.9K	3.4%
5	ESWATINI	$24.8K	3.1%
6	MONGOLIA	$24.3K	3.0%
7	YEMEN	$18.1K	2.3%
8	LAOS	$7.8K	1.0%
9	PHILIPPINES	$6.0K	0.7%
10	VENEZUELA	$5.2K	0.7%

IRAQ is India's largest gatifloxacin export destination, absorbing 47.7% of total exports worth $382.5K. The top 5 importing countries — IRAQ, UGANDA, UKRAINE, SAUDI ARABIA, ESWATINI — together account for 89.7% of India's total gatifloxacin export value. The remaining 41 destination countries collectively receive the other 10.3%, indicating a focused distribution strategy targeting key markets.

Who Supplies Gatifloxacin to India?

1 origin countries · Total import value: $2.4M

India imports gatifloxacin from 1 countries with a combined import value of $2.4M. The largest supplier is UNITED STATES ($2.4M, 17 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Gatifloxacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$2.4M	17	100.0%

UNITED STATES is the largest supplier of gatifloxacin to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Gatifloxacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for gatifloxacin, indicating its established presence in the U.S. market. Notably, there have been recent approvals, such as the ANDA granted to [Company Name] in January 2026. However, the FDA has issued Import Alert 66-76, effective March 26, 2025, targeting drugs from facilities that have not complied with the Generic Drug User Fee Amendments (GDUFA) requirements, including self-identification and fee payments. This alert subjects products from non-compliant facilities to detention without physical examination (DWPE). Given that 54 Indian exporters are involved in gatifloxacin shipments, it is imperative for these entities to ensure adherence to GDUFA mandates to maintain uninterrupted access to the U.S. market.

2EU & UK Regulatory Framework

In the European Union, gatifloxacin requires marketing authorization from the European Medicines Agency (EMA) before it can be marketed. The EMA evaluates the safety, efficacy, and quality of medicinal products. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval process. Manufacturers must comply with Good Manufacturing Practice (GMP) standards as outlined by the EMA and MHRA to ensure product quality and safety.

3WHO Essential Medicines & Global Standards

Gatifloxacin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating bacterial infections. The drug is also subject to international pharmacopoeia standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, gatifloxacin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, gatifloxacin is not listed under the Drug Price Control Order (DPCO), meaning it is not subject to price ceilings. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products, ensuring compliance with export regulations.

5Patent & Exclusivity Status

The primary patents for gatifloxacin have expired, allowing for generic competition in various markets. This has led to increased participation from multiple manufacturers, including the 54 Indian exporters noted in our data, contributing to the global availability and affordability of the drug.

6Recent Industry Developments

In August 2025, the FDA updated Import Alert 66-72, which pertains to the detention of misbranded drugs and marketed new drugs without approved applications. This revision emphasizes the need for manufacturers to ensure compliance with FDA regulations to avoid market disruptions.

In January 2026, the EMA issued a withdrawal notice for the marketing authorization of Zynquista (sotagliflozin), highlighting the agency's ongoing efforts to monitor and regulate the pharmaceutical market. While not directly related to gatifloxacin, such regulatory actions underscore the importance of maintaining compliance with EMA standards.

These developments highlight the dynamic nature of the pharmaceutical regulatory landscape and the necessity for exporters to stay informed and compliant with international standards to ensure market access and product integrity.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Gatifloxacin

Retail & reference prices across 9 markets vs. India FOB export price of $12.36/unit

Global Price Benchmark for Gatifloxacin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	Specific pricing data for Gatifloxacin in the United States is not readily available from public government sources.
United Kingdom	Data not available	GBP	Specific pricing data for Gatifloxacin in the United Kingdom is not readily available from public government sources.
Germany	Data not available	EUR	Specific pricing data for Gatifloxacin in Germany is not readily available from public government sources.
Australia	Data not available

Supply Chain Risk Assessment — Gatifloxacin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Gatifloxacin, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of KSMs used in Indian pharmaceutical manufacturing are sourced from China, making the supply chain vulnerable to disruptions. This dependency was highlighted in February 2025 when the FDA issued warning letters to API manufacturers in China and India for significant deviations from current Good Manufacturing Practice (cGMP), underscoring ongoing quality concerns.

To mitigate this risk, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic production of critical APIs and KSMs. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a significant step toward reducing import dependence.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Gatifloxacin from India account for 84.2% of total exports, with AJANTA PHARMA LIMITED alone contributing 47.7%. This high supplier concentration poses a significant single-source risk, as any disruption affecting these key exporters could severely impact global supply chains.

Access Complete Gatifloxacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 240 transactions across 46 markets.

Request Demo View Pricing

Frequently Asked Questions — Gatifloxacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top gatifloxacin exporters from India?

The leading gatifloxacin exporters from India are AJANTA PHARMA LIMITED, AUROLAB TRUST, DOSHI MEDICARE PRIVATE LIMITED, and 7 others. AJANTA PHARMA LIMITED leads with 47.7% market share ($382.5K). The top 5 suppliers together control 84.2% of total export value.

What is the total export value of gatifloxacin from India?

The total export value of gatifloxacin from India is $802.0K, recorded across 240 shipments from 54 active exporters to 46 countries. The average shipment value is $3.3K.

Which countries import gatifloxacin from India?

India exports gatifloxacin to 46 countries. The top importing countries are IRAQ (47.7%), UGANDA (26.0%), UKRAINE (9.6%), SAUDI ARABIA (3.4%), ESWATINI (3.1%), which together account for 89.7% of total export value.

What is the HS code for gatifloxacin exports from India?

The primary HS code for gatifloxacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Gatifloxacin

Gatifloxacin

Top Gatifloxacin Exporters from India

Top Countries Importing Gatifloxacin from India

Who Supplies Gatifloxacin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Gatifloxacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Gatifloxacin

Supply Chain Risk Assessment — Gatifloxacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Gatifloxacin Trade Intelligence

Frequently Asked Questions — Gatifloxacin Exports from India

Who are the top gatifloxacin exporters from India?

What is the total export value of gatifloxacin from India?

Which countries import gatifloxacin from India?

What is the HS code for gatifloxacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of gatifloxacin exports from India?

Which ports handle gatifloxacin exports from India?

Why is India a leading exporter of gatifloxacin?

What certifications do Indian gatifloxacin exporters need?

How many buyers import gatifloxacin from India?

What is the market share of the top gatifloxacin exporter from India?

Analysis Methodology